Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.

Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS Jr, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, Ling W.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):28-36. doi: 10.1016/j.drugalcdep.2008.06.016.

2.

Opioid antagonists with minimal sedation for opioid withdrawal.

Gowing L, Ali R, White JM.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002021. doi: 10.1002/14651858.CD002021.pub3. Review.

PMID:
19821290
3.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White JM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD002025. doi: 10.1002/14651858.CD002025.pub4. Review.

PMID:
19588330
4.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002025. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD002025.

PMID:
16625553
5.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002025. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD002025.

PMID:
15495026
6.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2000;(3):CD002025. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD002025.

PMID:
10908521
7.

Opioid dependence treatment, including buprenorphine/naloxone.

Raisch DW, Fye CL, Boardman KD, Sather MR.

Ann Pharmacother. 2002 Feb;36(2):312-21. Review.

PMID:
11847954
8.

Opioid antagonists with minimal sedation for opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002021. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD002021.

PMID:
16437438
9.

Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.

Orman JS, Keating GM.

Drugs. 2009;69(5):577-607. doi: 10.2165/00003495-200969050-00006. Review.

PMID:
19368419
10.

Opioid dependence: rationale for and efficacy of existing and new treatments.

Fiellin DA, Friedland GH, Gourevitch MN.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S173-7. Review.

11.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2002;(2):CD002025. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD002025.

PMID:
12076434
12.

The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.

Mammen K, Bell J.

Expert Opin Pharmacother. 2009 Oct;10(15):2537-44. doi: 10.1517/14656560903213405. Review.

PMID:
19708849
13.

Detoxification treatments for opiate dependent adolescents.

Minozzi S, Amato L, Bellisario C, Davoli M.

Cochrane Database Syst Rev. 2014 Apr 29;(4):CD006749. doi: 10.1002/14651858.CD006749.pub3. Review.

PMID:
24777492
14.

Buprenorphine and naloxone for heroin dependence.

Johnson RE, McCagh JC.

Curr Psychiatry Rep. 2000 Dec;2(6):519-26. Review.

PMID:
11123005
15.

A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.

Meader N.

Drug Alcohol Depend. 2010 Apr 1;108(1-2):110-4. doi: 10.1016/j.drugalcdep.2009.12.008. Review.

PMID:
20074867
16.

Spotlight on buprenorphine/naloxone in the treatment of opioid dependence.

Orman JS, Keating GM.

CNS Drugs. 2009 Oct;23(10):899-902. doi: 10.2165/11203740-000000000-00000. Review.

PMID:
19739698
17.

Opioid dependence treatment: options in pharmacotherapy.

Stotts AL, Dodrill CL, Kosten TR.

Expert Opin Pharmacother. 2009 Aug;10(11):1727-40. doi: 10.1517/14656560903037168. Review.

18.

Alpha2-adrenergic agonists in opioid withdrawal.

Gowing LR, Farrell M, Ali RL, White JM.

Addiction. 2002 Jan;97(1):49-58. Review.

PMID:
11895270
19.

Management of opioid painkiller dependence in primary care: ongoing recovery with buprenorphine/naloxone.

Hard B.

BMJ Case Rep. 2014 Nov 28;2014. pii: bcr2014207308. doi: 10.1136/bcr-2014-207308. Review.

20.

The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.

Dunn KE, Sigmon SC, Strain EC, Heil SH, Higgins ST.

Drug Alcohol Depend. 2011 Dec 1;119(1-2):1-9. doi: 10.1016/j.drugalcdep.2011.05.033. Review.

Items per page

Supplemental Content

Support Center